研究者データベース


フリーワードで探す

全文検索となっています

石倉 聡イシクラ サトシ

所属部署医学研究科共同研究教育センター
職名准教授
メールアドレス
ホームページURL
生年月日
Last Updated :2019/07/06

研究者基本情報

学歴

  •  - 1989年, 京都大学, 医学部

学位

  • 医学博士, 京都大学

研究活動情報

研究分野

  • 内科系臨床医学, 放射線科学

研究キーワード

    放射線腫瘍学

論文

  • Chemoradiotherapy in elderly patients with non-small cell lung cancer: long-term follow-up of a randomized trial (JCOG0301)., Atagi S, Mizusawa J, Ishikura S, Takahashi T, Okamoto H, Tanaka H, Goto K, Nakagawa K, Harada M, Takeda Y, Nogami N, Fujita Y, Kasai T, Kishi K, Sawa T, Takeda K, Tomii K, Satouchi M, Seto T, Ohe Y., Clic Lung Cancer,   2018年05月, 査読有り
  • Results of a multi-institutional, randomized, non-inferiority, phase 3 trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group study (JCOG0701)., Kodaira T, Kagami Y, Shibata T, Shikama N, Nishimura Y, Ishikura S, Nakamura K, Saito Y, Matsumoto Y, Teshima T, Ito Y, Akimoto T, Nakata K, Toshiyasu T, Nakagawa K, Nagata Y, Nishimura T, Uno T, Kataoka M, Yorozu A, Hiraoka M; Radiation Therapy Study Group of the Japan Clinical Oncology Group., Ann Oncol, 29, 992 - 997,   2018年04月, 査読有り
  • Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: a phase I study., Kato K, Ura T, Koizumi W, Iwasa S, Katada C, Azuma M, Ishikura S, Nakao Y, Onuma H, Muro K., Cancer Sci, 109, 785 - 793,   2018年03月, 査読有り
  • A virtual dosimetry audit – Towards transferability of gamma index analysis between clinical trial QA groups., Hussein M, Clementel E, Eaton D, Greer P, Haworth A, Ishikura S, Kry S, Lehmann J, Lye J, Monti A, Nakamura M, Hurkmans C, Clark C., Radiother Oncol, 125, 398 - 404,   2017年12月, 査読有り
  • A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors., Iwata H, Ishikura S, Murai T, Iwabuchi M, Inoue M, Tatewaki K, Ohta S, Yokota N, Shibamoto Y, International journal of clinical oncology, 22, (4) 706 - 714,   2017年08月, 査読有り
  • Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303)., Okuno T, Wakabayashi M, Kato K, Shinoda M, Katayama H, Igaki H, Tsubosa Y, Kojima T, Okabe H, Kimura Y, Kawano T, Kosugi S, Toh Y, Kato H, Nakamura K, Fukuda H, Ishikura S, Ando N, Kitagawa Y, Japan Esophageal Oncology Group/Japan Clinical Oncology Group., International journal of clinical oncology,   2017年07月, 査読有り
  • Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011)., Sekine I, Harada H, Yamamoto N, Wakabayashi M, Murakami H, Goto K, Nogami N, Seto T, Oshita F, Okamoto H, Tanaka H, Tamura T, Ishikura S, Ohe Y, Lung cancer (Amsterdam, Netherlands), 108, 232 - 237,   2017年06月, 査読有り
  • Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV⩾100cc., Onimaru R, Onishi H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 122, (2) 281 - 285,   2017年02月, 査読有り
  • A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology, Kimura T, Nagata Y, Eba J, Ozawa S, Ishikura S, Shibata T, Ito Y, Hiraoka M, Nishimura Y, Radiation Oncology Study Group of the Japan Clinical Oncology Group ., Japanese journal of clinical oncology,   2017年01月, 査読有り
  • Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A)., Eba J, Nakamura K, Mizusawa J, Suzuki K, Nagata Y, Koike T, Hiraoka M, Watanabe S, Ishikura S, Asamura H, Fukuda H, Lung Cancer Surgical Study Group and the Radiation Therapy Study Group of the Japan Clinical Oncology Group., Japanese journal of clinical oncology, 46, (8) 748 - 753,   2016年08月, 査読有り
  • An on-site audit system for dosimetry credentialing of intensity-modulated radiotherapy in Japanese Clinical Oncology Group (JCOG) clinical trials., Nakamura M, Minemura T, Ishikura S, Nishio T, Narita Y, Nishimura Y, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 32, (8) 987 - 991,   2016年08月, 査読有り
  • In Regard to Nagata et al., Nagata Y, Shibata T, Ishikura S, International journal of radiation oncology, biology, physics, 95, (4) ,   2016年07月, 査読有り
  • Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 study., Hamamoto Y, Mizusawa J, Katayama H, Nakamura K, Kato K, Tsubosa Y, Ishikura S, Igaki H, Shinoda M, Fukuda H, Kitagawa Y, Ando N, Japanese journal of clinical oncology, 46, (4) 389 - 392,   2016年04月, 査読有り
  • Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancer., Sekine I, Sumi M, Satouchi M, Tsujino K, Nishio M, Kozuka T, Niho S, Nihei K, Yamamoto N, Harada H, Ishikura S, Tamura T, Cancer science, 107, (3) 315 - 319,   2016年03月, 査読有り
  • Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403., Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K, Mitsuhashi N, Ishikura S, International journal of radiation oncology, biology, physics, 93, (5) 989 - 996,   2015年12月, 査読有り
  • A questionnaire-based survey on 3D image-guided brachytherapy for cervical cancer in Japan: advances and obstacles., Ohno T, Toita T, Tsujino K, Uchida N, Hatano K, Nishimura T, Ishikura S, Journal of radiation research, 56, (6) 897 - 903,   2015年11月, 査読有り
  • Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702)., Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Onishi H, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 116, (2) 276 - 280,   2015年08月, 査読有り
  • Dose calculation accuracies in whole breast radiotherapy treatment planning: a multi-institutional study., Hatanaka S, Miyabe Y, Tohyama N, Kumazaki Y, Kurooka M, Okamoto H, Tachibana H, Kito S, Wakita A, Ohotomo Y, Ikagawa H, Ishikura S, Nozaki M, Kagami Y, Hiraoka M, Nishio T, Radiological physics and technology, 8, (2) 200 - 208,   2015年07月, 査読有り
  • Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)., Shinoda M, Ando N, Kato K, Ishikura S, Kato H, Tsubosa Y, Minashi K, Okabe H, Kimura Y, Kawano T, Kosugi S, Toh Y, Nakamura K, Fukuda H, Japan Clinical Oncology Group., Cancer science, 106, (4) 407 - 412,   2015年04月, 査読有り
  • A new two-step accurate CT-MRI fusion technique for post-implant prostate cancer., Kunogi H, Hojo H, Wakumoto Y, Saito AI, Ishikura S, Yamashiro Y, Kuwatsuru R, Sasai K, Journal of contemporary brachytherapy, 7, (2) 117 - 121,   2015年04月, 査読有り
  • Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM., Kodaira T, Nishimura Y, Kagami Y, Ito Y, Shikama N, Ishikura S, Hiraoka M, Japanese journal of clinical oncology, 45, (3) 235 - 243,   2015年03月, 査読有り
  • Global harmonization of quality assurance naming conventions in radiation therapy clinical trials., Melidis C, Bosch WR, Izewska J, Fidarova E, Zubizarreta E, Ulin K, Ishikura S, Followill D, Galvin J, Haworth A, Besuijen D, Clark CH, Miles E, Aird E, Weber DC, Hurkmans CW, Verellen D, International journal of radiation oncology, biology, physics, 90, (5) 1242 - 1249,   2014年12月, 査読有り
  • Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors., Nishimura S, Takeda A, Sanuki N, Ishikura S, Oku Y, Aoki Y, Kunieda E, Shigematsu N, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 9, (9) 1370 - 1376,   2014年09月, 査読有り
  • Randomized phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck: Japan Clinical Oncology Group Study (JCOG1008)., Kunieda F, Kiyota N, Tahara M, Kodaira T, Hayashi R, Ishikura S, Mizusawa J, Nakamura K, Fukuda H, Fujii M, Head and Neck Cancer Study Group of the Japan Clinical Oncology Group., Japanese journal of clinical oncology, 44, (8) 770 - 774,   2014年08月, 査読有り
  • Radiation therapy quality assurance in clinical trials--Global Harmonisation Group., Melidis C, Bosch WR, Izewska J, Fidarova E, Zubizarreta E, Ishikura S, Followill D, Galvin J, Xiao Y, Ebert MA, Kron T, Clark CH, Miles EA, Aird EG, Weber DC, Ulin K, Verellen D, Hurkmans CW, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 111, (3) 327 - 329,   2014年06月, 査読有り
  • Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer., Manabe Y, Shibamoto Y, Sugie C, Baba F, Ayakawa S, Nagai A, Takemoto S, Hayashi A, Kawai N, Takeuchi M, Ishikura S, Kohri K, Yanagi T, Journal of radiation research, 55, (3) 494 - 501,   2014年05月, 査読有り
  • Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology Group trial, Nishio T, Shirato H, Ishikawa M, Miyabe Y, Kito S, Narita Y, Onimaru R, Ishikura S, Ito Y, Hiraoka M, Journal of radiation research, 55, (3) 600 - 607,   2014年05月, 査読有り
  • Survey of advanced radiation technologies used at designated cancer care hospitals in Japan., Shikama N, Tsujino K, Nakamura K, Ishikura S, Japanese journal of clinical oncology, 44, (1) 72 - 77,   2014年01月, 査読有り
  • Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study., Kubota K, Hida T, Ishikura S, Mizusawa J, Nishio M, Kawahara M, Yokoyama A, Imamura F, Takeda K, Negoro S, Harada M, Okamoto H, Yamamoto N, Shinkai T, Sakai H, Matsui K, Nakagawa K, Shibata T, Saijo N, Tamura T, Japan Clinical Oncology Group., The Lancet. Oncology, 15, (1) 106 - 113,   2014年01月, 査読有り
  • Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy., Tatekawa K, Iwata H, Kawaguchi T, Ishikura S, Baba F, Otsuka S, Miyakawa A, Iwana M, Shibamoto Y, Radiation oncology (London, England), 9,   2014年01月, 査読有り
  • Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer., Harada H, Nishio M, Murakami H, Ohyanagi F, Kozuka T, Ishikura S, Naito T, Kaira K, Takahashi T, Horiike A, Nishimura T, Yamamoto N, Clinical lung cancer, 14, (4) 440 - 445,   2013年07月, 査読有り
  • Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer., Kasuya G, Toita T, Furutani K, Kodaira T, Ohno T, Kaneyasu Y, Yoshimura R, Uno T, Yogi A, Ishikura S, Hiraoka M, Radiation oncology (London, England), 8,   2013年06月, 査読有り
  • Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck., Okano S, Yoshino T, Fujii M, Onozawa Y, Kodaira T, Fujii H, Akimoto T, Ishikura S, Oguchi M, Zenda S, de Blas B, Tahara M, Beier F, Japanese journal of clinical oncology, 43, (5) 476 - 482,   2013年05月, 査読有り
  • Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study., Eriguchi T, Takeda A, Oku Y, Ishikura S, Kimura T, Ozawa S, Nakashima T, Matsuo Y, Nakamura M, Matsumoto Y, Yamazaki S, Sanuki N, Ito Y, Radiation oncology (London, England), 8,   2013年05月, 査読有り
  • Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)., Atagi S, Kawahara M, Yokoyama A, Okamoto H, Yamamoto N, Ohe Y, Sawa T, Ishikura S, Shibata T, Fukuda H, Saijo N, Tamura T, Japan Clinical Oncology Group Lung Cancer Study Group., The Lancet. Oncology, 13, (7) 671 - 678,   2012年07月, 査読有り
  • Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303., Sanuki N, Ishikura S, Shinoda M, Ito Y, Hayakawa K, Ando N, International journal of clinical oncology, 17, (2) 105 - 111,   2012年04月, 査読有り
  • Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study., Shibamoto Y, Hashizume C, Baba F, Ayakawa S, Manabe Y, Nagai A, Miyakawa A, Murai T, Iwata H, Mori Y, Mimura M, Ishikura S, Cancer, 118, (8) 2078 - 2084,   2012年04月, 査読有り
  • Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges., Ishikura S, General thoracic and cardiovascular surgery, 60, (3) 127 - 131,   2012年03月, 査読有り
  • Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906)., Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y, Fukuda H, Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG)., International journal of radiation oncology, biology, physics, 81, (3) 684 - 690,   2011年11月, 査読有り
  • JCOG Radiation Therapy Study Group: history and achievements., Ishikura S, Ito Y, Hiraoka M, Japanese journal of clinical oncology, 41, (11) 1241 - 1243,   2011年11月, 査読有り
  • A consensus-based guideline defining clinical target volume for primary disease in external beam radiotherapy for intact uterine cervical cancer., Toita T, Ohno T, Kaneyasu Y, Kato T, Uno T, Hatano K, Norihisa Y, Kasamatsu T, Kodaira T, Yoshimura R, Ishikura S, Hiraoka M, JCOG Radiation Therapy Study Group., Japanese journal of clinical oncology, 41, (9) 1119 - 1126,   2011年09月, 査読有り
  • Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG1066): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer., Toita T, Kato S, Ishikura S, Tsujino K, Kodaira T, Uno T, Hatano K, Sakurai H, Niibe Y, Kazumoto T, Nishimura T, Kitagawa R, Fukutani M, Oguchi M, Umayahara K, Hirashima Y, Aoki Y, Takizawa K, Disease Committee of Radiation Oncology,Japanese Gynecologic Oncology Group., International journal of clinical oncology, 16, (4) 379 - 386,   2011年08月, 査読有り
  • A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer., Japan Clinical Oncology Group., Toita T, Ohno T, Kaneyasu Y, Uno T, Yoshimura R, Kodaira T, Furutani K, Kasuya G, Ishikura S, Kamura T, Hiraoka M, Japanese journal of clinical oncology, 40, (5) 456 - 463,   2010年05月, 査読有り
  • Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study., Spoelstra FO, Senan S, Le Péchoux C, Ishikura S, Casas F, Ball D, Price A, De Ruysscher D, van Sörnsen de Koste JR, Lung Adjuvant Radiotherapy Trial Investigators Group., International journal of radiation oncology, biology, physics, 76, (4) 1106 - 1113,   2010年03月, 査読有り
  • A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma., Yoshikawa T, Tsuburaya A, Hirabayashi N, Yoshida K, Nagata N, Kodera Y, Takahashi N, Oba K, Kimura M, Ishikura S, Miyashita Y, Sakamoto J, Cancer chemotherapy and pharmacology, 64, (6) 1071 - 1077,   2009年11月, 査読有り
  • Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211., Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27, (33) 5594 - 5600,   2009年11月, 査読有り
  • A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708)., Kato H, Sato A, Fukuda H, Kagami Y, Udagawa H, Togo A, Ando N, Tanaka O, Shinoda M, Yamana H, Ishikura S, Japanese journal of clinical oncology, 39, (10) 638 - 643,   2009年10月, 査読有り
  • Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus., Onozawa M, Nihei K, Ishikura S, Minashi K, Yano T, Muto M, Ohtsu A, Ogino T, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 92, (2) 266 - 269,   2009年08月, 査読有り
  • Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202., Sanuki-Fujimoto N, Ishikura S, Hayakawa K, Kubota K, Nishiwaki Y, Tamura T, Radiation oncology (London, England), 4,   2009年06月, 査読有り
  • Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care., Ishikura S, Japanese journal of clinical oncology, 38, (11) 723 - 729,   2008年11月, 査読有り
  • Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701)., Nakamura K, Kodaira T, Shikama N, Kagami Y, Ishikura S, Shibata T, Hiraoka M, Japanese journal of clinical oncology, 38, (5) 387 - 389,   2008年05月, 査読有り
  • Feasibility study of glass dosimeter postal dosimetry audit of high-energy radiotherapy photon beams., Mizuno H, Kanai T, Kusano Y, Ko S, Ono M, Fukumura A, Abe K, Nishizawa K, Shimbo M, Sakata S, Ishikura S, Ikeda H, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 86, (2) 258 - 263,   2008年02月, 査読有り
  • A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer., Hiraoka M, Ishikura S, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2, (7 Suppl 3) S115 - 7,   2007年07月, 査読有り
  • Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer., Matsuo Y, Takayama K, Nagata Y, Kunieda E, Tateoka K, Ishizuka N, Mizowaki T, Norihisa Y, Sakamoto M, Narita Y, Ishikura S, Hiraoka M, International journal of radiation oncology, biology, physics, 68, (2) 416 - 425,   2007年06月, 査読有り
  • [Field Survey Results on Output for X-ray Therapeutic Accelerators in Radiotherapy Institutions of Saitama and Tochigi Prefectures.]., Enokido Y, Okamoto H, Kiyomiya Y, Furuya T, Fujimori K, Kusano Y, Touyama N, Goka T, Ooyama M, Minemura T, Kutsutani-Nakamura Y, Shimbo M, Tabushi K, Ishikura S, Endou M, Ikeda H, Igaku butsuri : Nihon Igaku Butsuri Gakkai kikanshi = Japanese journal of medical physics : an official journal of Japan Society of Medical Physics, 27, (2) 71 - 77,   2007年, 査読有り
  • Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403)., Nishio T, Kunieda E, Shirato H, Ishikura S, Onishi H, Tateoka K, Hiraoka M, Narita Y, Ikeda M, Goka T, Physics in medicine and biology, 51, (21) 5409 - 5417,   2006年11月, 査読有り
  • Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer., Sekine I, Nokihara H, Sumi M, Saijo N, Nishiwaki Y, Ishikura S, Mori K, Tsukiyama I, Tamura T, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 1, (8) 810 - 815,   2006年10月, 査読有り
  • High-dose proton beam therapy for Stage I non-small-cell lung cancer., Nihei K, Ogino T, Ishikura S, Nishimura H, International journal of radiation oncology, biology, physics, 65, (1) 107 - 111,   2006年05月, 査読有り
  • Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma., Yoshino T, Nakamura S, Matsuno Y, Ochiai A, Yokoi T, Kitadai Y, Suzumiya J, Tobinai K, Kobayashi Y, Oda I, Mera K, Ohtsu A, Ishikura S, Cancer science, 97, (2) 163 - 166,   2006年02月, 査読有り
  • Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan., Nihei K, Ogino T, Ishikura S, Kawashima M, Nishimura H, Arahira S, Onozawa M, Japanese journal of clinical oncology, 35, (12) 745 - 752,   2005年12月, 査読有り
  • Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach., Ishikura S, Tobinai K, Ohtsu A, Nakamura S, Yoshino T, Oda I, Takagi T, Mera K, Kagami Y, Itoh K, Tamaki Y, Suzumiya J, Taniwaki M, Yamamoto S, Cancer science, 96, (6) 349 - 352,   2005年06月, 査読有り
  • Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer., Tahara M, Ohtsu A, Hironaka S, Boku N, Ishikura S, Miyata Y, Ogino T, Yoshida S, Japanese journal of clinical oncology, 35, (6) 316 - 323,   2005年06月, 査読有り
  • Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812)., Atagi S, Kawahara M, Tamura T, Noda K, Watanabe K, Yokoyama A, Sugiura T, Senba H, Ishikura S, Ikeda H, Ishizuka N, Saijo N, Japan Clinical Oncology Group (JCOG9812)., Japanese journal of clinical oncology, 35, (4) 195 - 201,   2005年04月, 査読有り
  • A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC)., Ishikura S, Ohe Y, Nihei K, Kubota K, Kakinuma R, Ohmatsu H, Goto K, Niho S, Nishiwaki Y, Ogino T, International journal of radiation oncology, biology, physics, 61, (4) 1117 - 1122,   2005年03月, 査読有り
  • Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus., Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A, International journal of radiation oncology, biology, physics, 57, (2) 425 - 433,   2003年10月, 査読有り
  • [Controversies in the treatment of esophageal cancer from the viewpoint of medical oncology]., Ohtsu A, Muto M, Mera K, Ishikura S, Gan to kagaku ryoho. Cancer & chemotherapy, 30, (9) 1230 - 1237,   2003年09月, 査読有り
  • EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer., Hattori S, Muto M, Ohtsu A, Boku N, Manabe T, Doi T, Ishikura S, Yoshida S, Gastrointestinal endoscopy, 58, (1) 65 - 70,   2003年07月, 査読有り
  • Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus., Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T, Yoshida S, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21, (14) 2697 - 2702,   2003年07月, 査読有り
  • Efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer., Ito Y, Ohtsu A, Ishikura S, Boku N, Nihei K, Ogino T, Ikeda H, Japanese journal of clinical oncology, 33, (4) 180 - 185,   2003年04月, 査読有り
  • Short-course palliative radiotherapy for airway stenosis in non-small cell lung cancer., Nihei K, Ishikura S, Kawashima M, Ogino T, Ito Y, Ikeda H, International journal of clinical oncology, 7, (5) 284 - 288,   2002年10月, 査読有り
  • Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus., Ishikura S, Ogino T, Furuse J, Satake M, Baba S, Kawashima M, Nihei K, Ito Y, Maru Y, Ikeda H, American journal of clinical oncology, 25, (2) 189 - 193,   2002年04月, 査読有り
  • Advanced esophageal cancer with esophago-bronchial fistula successfully treated by chemoradiation therapy with additional endoscopic resection: a case report., Morihiro M, Boku N, Ohtsu A, Miyamoto S, Ishikura S, Japanese journal of clinical oncology, 32, (2) 59 - 63,   2002年02月, 査読有り

受賞

  •   2016年11月, 日本放射線腫瘍学会, 優秀教育講演賞
  •   2015年05月, 15th International Congress of Radiation Research, 優秀ポスター賞
  •   2009年, 国立がんセンター, 田宮記念賞
  •   1999年06月, 日本食道疾患研究会, 会長賞


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.